Table 2. Pretreatment and Posttreatment Sinclair Grades for Patients With Persistent Chemotherapy-Induced Alopecia (DA and FPHL Only) Who Received 6 Months or More of Treatment.
| Treatment | No. of patients | Mean (SD) duration of treatment, mo | Sinclair grade treatment, median (IQR) | P value | |
|---|---|---|---|---|---|
| Before | After | ||||
| Topical minoxidil | 21 | 17 (17) | 4 (3-5) | 3 (2.5-4) | .002 |
| LDOM | 18 | 29 (28) | 4 (2-5) | 2.5 (2-4) | .002 |
| LDOM and antiandrogena | 10 | 33 (25) | 5 (2-5) | 3 (2-5) | .03 |
| Any treatment | 49 | 25 (24) | 4 (3-5) | 3 (2-4) | <.001 |
Abbreviations: DA, diffuse alopecia; FPHL, female pattern hair loss; LDOM, low-dose oral minoxidil.
a
Antiandrogen: spironolactone, flutamide, or bicalutamide.